Complementary Peptides For Beta-Amyloid 29-42 Peptide
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Aug 14, 2008
app pub date -
Oct 6, 2005
filing date -
Oct 8, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention relates to peptides derived from the wild type ApolipoproteinE3 peptidic fragment 270-287 (ApoE WT) of sequence EDMQRQWAGLVEKVQAAV (SEQ ID NO: 2), having improved interaction with the .beta.-Amyloid peptidic fragment 29-42 (A.beta. 29-42) GAIIGLMVGGVVIA (SEQ ID NO: 1), in a [A.beta. 29-42/ApoE mutant n] complex.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully